Reactions to the Wegovy Injection: Knowing When to Act

Reactions at the injection site: what the skin does and why

A small patch of redness, a faint welt, or brief itching at the spot where you injected is the most frequently reported type of Wegovy injection site reaction. The subcutaneous tissue is reacting to both the needle and the formulation itself, and that reaction generally peaks within an hour and resolves by the next morning. Mild bruising is also common, particularly if you happened to nick a small vessel.

Rotating between sites (abdomen, outer thigh, back of the upper arm) reduces the chance of localised irritation building up. If you want a closer look at the pen itself before your first use, our guide to the Wegovy injections walks through what comes in the box and how the device is designed. Cleaning the skin first with an alcohol swab and letting it dry fully before inserting the needle cuts the risk of introducing bacteria.

If the injection site becomes increasingly red, warm to the touch, swollen or painful over 24–48 hours rather than settling, that pattern points to a localised infection rather than a normal reaction. That warrants a call to your GP or, out of hours, NHS 111. Pus or spreading redness is always a reason to be seen. More detail on technique (including upper arm injections, which some people find less reactive) is covered on our guide to the arm as an injection site.

Whole-body reactions: sorting the expected from the concerning

Semaglutide slows the rate at which the stomach empties food, and that mechanism is behind the gastrointestinal reactions that many people notice, especially after the first few doses or following a dose increase. Nausea is the most common; loose stools, indigestion, burping and fatigue follow. For most people these are inconvenient rather than distressing, and they fade within a couple of weeks at any given dose level.

The decision point here is severity and duration. If nausea is stopping you eating or drinking for more than a day, or if vomiting or diarrhoea is persistent enough to risk dehydration, that matters. Dehydration can affect kidney function in a way that is clinically meaningful, and it is worth contacting a clinician rather than waiting it out. The full overview of how Wegovy works explains why these GI effects happen and how the dose escalation schedule is designed to keep them manageable.

Some people also notice headaches or dizziness in the first few weeks. These are listed on the NHS side-effect profile for semaglutide and typically resolve. If dizziness is severe or accompanied by changes in vision, get it checked the same day.

Reactions that need prompt medical attention

This is the category worth understanding before you ever need it.

The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, infrequent but potentially serious reaction associated with GLP-1 medicines. The symptom to recognise is severe, persistent pain in the upper abdomen that may spread through to the back, sometimes alongside vomiting. If that happens, stop the injection and go to A&E or call 999, do not wait to see if it passes.

Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a widespread rash or a sudden drop in blood pressure) are rare but require emergency help immediately. Mild itching at the site is not this; a closing throat is.

If you develop gallbladder symptoms (right-sided pain under the ribs, pain after eating fatty food, nausea with that pain), tell your GP. Gallbladder problems occur at a higher rate in people losing weight rapidly and have been noted in the clinical trial data for semaglutide. A practical note: if you're planning a longer holiday or a period when reaching a clinician quickly would be harder than usual, it is worth having a conversation with your prescriber beforehand about what to monitor. Knowing when to pause a dose can prevent a minor reaction from becoming something worse.

For anything you're unsure about, you can reach our support team seven days a week, or report a suspected reaction directly to the MHRA Yellow Card scheme, this reporting matters because it helps regulators track patterns in real-world use.

Deciding what your reaction means for your treatment going forward

Most reactions to the Wegovy injection are not reasons to stop. They are, however, reasons to communicate, with your prescriber, with our support team, or with a GP if you are elsewhere in the system. The dose titration schedule exists precisely to reduce the likelihood of significant reactions; our page on how to take the Wegovy injection covers each step carefully and explains why not rushing through dose increases keeps that protection in place.

If a reaction has left you uncertain about whether to continue, that uncertainty itself is worth raising at your next clinical review. Decisions about slowing the titration, temporarily pausing, or investigating an unusual response are clinical decisions, the kind our prescribers make as part of every repeat review, not just the first one. There is no point at which a question about how you are tolerating treatment is too small to mention, and if you are approaching your target, it is also worth reading about what happens when you reach your goal weight on Wegovy so you know what to expect next. You can explore treatment options and start a free consultation if you haven't yet, or speak to a prescriber about suitability and what to expect at each stage.

The NHS England guidance on weight management injections also covers what monitoring is expected during treatment, which is worth reading alongside your Patient Information Leaflet.